EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Cancer Clinician Experiences With Telehealth Across Oncology Specialties: Cross-Sectional Survey Study

Benjamin Baker iD, Sakshith Reddy Chintala iD, Sarah Azari iD, James D Murphy iD, Hala Madanat iD, Maria Elena Martinez iD, Richard M Cripps iD, Aditya Bagrodia iD, Humberto Parada iD, Juan Javier-DesLoges iD

JMIR Cancer · 19.08.2026 · 12 · e94610-e94610

DOI: 10.2196/94610 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JMIR Cancer, online erschienen am 19.08.2026. Verfasst von Benjamin Baker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of California, San Diego, 200 W. Arbor Drive #8897, San Diego, CA, 92103-8897, United States, 1 (619) 543-2626. Hauptthemen laut MEDLINE: Telemedicine, COVID-19, Medical Oncology, Neoplasms. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Telehealth use expanded rapidly during the COVID-19 pandemic and has since become integrated into routine oncology care. However, clinician experiences and confidence with telehealth may vary across oncology subspecialties, and these differences remain incompletely characterized.

Objective

This study aimed to evaluate telehealth perceptions, decision-making factors, and confidence across oncology clinicians from multiple specialties at a single academic cancer center.

Methods

We conducted a cross-sectional survey of oncology clinicians at the University of California San Diego Moores Cancer Center. A 27-item Qualtrics questionnaire was distributed by email to attending physicians, fellows, and advanced practice providers across surgical, medical, radiation, and palliative oncology. Survey domains included telehealth coordination, technical quality, communication effectiveness, confidence in remote physical examination, and factors influencing visit modality selection. Quantitative responses were summarized descriptively, and open-ended responses underwent thematic analysis.

Results

Among 114 invited clinicians, 57 (50%) complete responses were analyzed. Among 57 respondents, 86% (n=49) were physicians. Specialties included surgical oncology (n=21, 36.8%), medical oncology (n=18, 31.6%), radiation oncology (n=16, 28.1%), and palliative care (n=2, 3.5%). Telehealth coordination was rated easy or very easy by 78.9% (n=45) of clinicians. Audio and video quality were rated good or very good by 71.9% (n=41) and 57.9% (n=33), respectively. Technical issues prompted at least occasional conversion to audio-only visits for 86% (n=49) of respondents, and 17.5% (n=10) of clinicians reported frequent conversion. Communication satisfaction was high (n=48, 84.2%), yet only 50.9% (n=29) reported moderate or high confidence in performing a virtual physical examination. The need for physical examination (n=53, 93%) and patient travel distance (n=45, 78.9%) were the most influential factors in offering telehealth visits. Confidence varied by specialty and clinical phase: moderate or high confidence was reported by surgical oncology clinicians in 52.4% (11/21) of preoperative and 71.4% (15/21) of postoperative responses, by medical oncology clinicians in 77.8% (14/18) of prechemotherapy and 76.5% (13/17) of during chemotherapy responses, and by radiation oncology clinicians in 87.5% (14/16) of preradiation and 93.8% (15/16) of during radiation responses.

Conclusions

Oncology clinicians reported generally positive experiences with telehealth, although confidence and use patterns varied across specialties and phases of care. Telehealth is viewed as a complementary modality when physical examination is not essential. Improvements in technical reliability and interpreter integration may enhance equitable access and support continued telehealth use in oncology care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineCOVID-19Medical OncologyNeoplasmsOncologistsHumansCross-Sectional StudiesSurveys and QuestionnairesFemaleMaleSARS-CoV-2PandemicsAttitude of Health PersonnelAdult

Stichwörter der Autor:innen

cancer care deliveryclinician experiencedigital healthoncologytelehealthtelemedicine

Autor:innen und Institutionen

  • Department of Urology, University of California, San Diego, 200 W. Arbor Drive #8897, San Diego, CA, 92103-8897, United States, 1 (619) 543-2626.
  • Department of Radiation Medicine and Applied Sciences, Unviersity of California San Deigo, La Jolla, CA, United States.
  • Department of Biology, San Diego State University, San Diego, CA, United States.
  • Herbert Wertheim School of Public Health and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States.
  • Department of Epidemiology and Biostatistics, School of Public Health, San Diego State University, San Diego, CA, United States.

ORCID-Profile: Benjamin Baker, Sakshith Reddy Chintala, Sarah Azari, James D Murphy, Hala Madanat, Maria Elena Martinez, Richard M Cripps, Aditya Bagrodia, Humberto Parada, Juan Javier-DesLoges

Förderung

  • NCI NIH HHS

Zitieren

APA

Baker, B., Chintala, S. R., Azari, S., Murphy, J. D., Madanat, H., Martinez, M. E., Cripps, R. M., Bagrodia, A., Parada, H., & Javier-DesLoges, J. (2026). Cancer Clinician Experiences With Telehealth Across Oncology Specialties: Cross-Sectional Survey Study. JMIR Cancer, 12, e94610-e94610. https://doi.org/10.2196/94610

Vancouver

Baker B, Chintala SR, Azari S, Murphy JD, Madanat H, Martinez ME, et al. Cancer Clinician Experiences With Telehealth Across Oncology Specialties: Cross-Sectional Survey Study. JMIR Cancer. 2026;12:e94610-e94610. doi:10.2196/94610

BibTeX
@article{Baker2026,
  author = {Baker, Benjamin and Chintala, Sakshith Reddy and Azari, Sarah and Murphy, James D and Madanat, Hala and Martinez, Maria Elena and Cripps, Richard M and Bagrodia, Aditya and Parada, Humberto and Javier-DesLoges, Juan},
  title = {Cancer Clinician Experiences With Telehealth Across Oncology Specialties: Cross-Sectional Survey Study},
  journal = {JMIR Cancer},
  year = {2026},
  volume = {12},
  pages = {e94610--e94610},
  doi = {10.2196/94610}
}
Kostenlos starten →